Senior insider sale
SVP, Commercial Operations at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$239.7K
4.44K shares
What this filing means
HORICH WILLIAM TODD plans to sell 4.44K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $239.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001950047-26-002383
Officer· SVP, Commercial Operations
Since Mar 2026
4.44K
Shares to sell
$239.7K
Approx. market value
4.44K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted stock vesting under a registered plan
Employee stock unit award(s)
2/23/2026
2.89KRestricted stock vesting under a registered plan
Employee stock unit award(s)
2/22/2026
1KRestricted stock vesting under a registered plan
Employee stock unit award(s)
2/19/2026
544.00Total acquired4.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/23/2026 | Restricted stock vesting under a registered plan Employee stock unit award(s) | 2.89K | — |
2/22/2026 | Restricted stock vesting under a registered plan Employee stock unit award(s) | 1K | — |
2/19/2026 | Restricted stock vesting under a registered plan Employee stock unit award(s) | 544.00 | — |
| Total | 4.44K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.44K
Market value
$239.7K
3/9/2026
Total
Units
4.44K
Value
$239.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/9/2026 | 4.44K | $239.7K | NASDAQ | Planned |
| Total | 4.44K | $239.7K | ||